Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.690
+0.010 (0.37%)
Aug 1, 2025, 4:00 PM - Market closed
Augmedix Employees
Kalaris Therapeutics had 14 employees as of December 31, 2024.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,425,429
Market Cap
50.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KLRS News
- 2 months ago - Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference - GlobeNewsWire
- 2 months ago - Kalaris to Participate at Stifel Ophthalmology Forum - GlobeNewsWire
- 2 months ago - Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 4 months ago - Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - GlobeNewsWire
- 4 months ago - Kalaris Announces Closing of Merger with AlloVir - GlobeNewsWire